148 related articles for article (PubMed ID: 1450504)
1. Fatal pneumonia caused by Corynebacterium group JK after treatment of Staphylococcus aureus pneumonia.
Yoshitomi Y; Kohno S; Koga H; Maesaki S; Higashiyama Y; Matsuda H; Mitsutake K; Miyazaki Y; Yamada H; Hara K
Intern Med; 1992 Jul; 31(7):930-2. PubMed ID: 1450504
[TBL] [Abstract][Full Text] [Related]
2. Multiresistant Corynebacterium xerosis as a cause of pneumonia in a patient with acute leukemia.
Wallet F; Marquette CH; Courcol RJ
Clin Infect Dis; 1994 May; 18(5):845-6. PubMed ID: 8075298
[No Abstract] [Full Text] [Related]
3. [Pneumonia caused byCorynebacterium pseudodiphtheriticum].
Furiasse D; Gasparotto AM; Monterisi A; Castellano G; Rocchi M
Rev Argent Microbiol; 2016; 48(4):290-292. PubMed ID: 27836329
[TBL] [Abstract][Full Text] [Related]
4. Pathology of culture-proven JK Corynebacterium pneumonia. An autopsy case report.
Waters BL
Am J Clin Pathol; 1989 May; 91(5):616-9. PubMed ID: 2718963
[TBL] [Abstract][Full Text] [Related]
5. A retrospective analysis of carbapenem-resistant Acinetobacter baumannii-mediated nosocomial pneumonia and the in vitro therapeutic benefit of cefoperazone/sulbactam.
Xia J; Zhang D; Xu Y; Gong M; Zhou Y; Fang X
Int J Infect Dis; 2014 Jun; 23():90-3. PubMed ID: 24726664
[TBL] [Abstract][Full Text] [Related]
6. Three cases of opportunistic infection caused by propionic acid producing Corynebacterium minutissimum.
Van Bosterhaut B; Cuvelier R; Serruys E; Pouthier F; Wauters G
Eur J Clin Microbiol Infect Dis; 1992 Jul; 11(7):628-31. PubMed ID: 1396773
[TBL] [Abstract][Full Text] [Related]
7. [Cefoperazone-sulbactam plus minocycline in the treatment of extensively drug resistant Acinetobacter infections].
Shi Y; Xu YC; Liu Y; Du W; Rui X; Wang Y
Zhonghua Yi Xue Za Zhi; 2012 Oct; 92(40):2847-50. PubMed ID: 23290215
[TBL] [Abstract][Full Text] [Related]
8. Group JK diphtheroid bacteremia. The successive isolation of an antibiotic-susceptible and an antigenically different multi-resistant strain.
Heltberg O; Friis-Møller A; Ersgaard H
Acta Pathol Microbiol Immunol Scand B; 1986 Aug; 94(4):285-9. PubMed ID: 3751582
[TBL] [Abstract][Full Text] [Related]
9. Corynebacterium pseudodiphtheriticum pneumonitis in a leukaemic child.
Cimolai N; Rogers P; Seear M
Thorax; 1992 Oct; 47(10):838-9. PubMed ID: 1481190
[TBL] [Abstract][Full Text] [Related]
10. Corynebacterium Group JK pathogen in cerebrospinal fluid shunt infection. Report of two cases.
Keren G; Geva T; Bogokovsky B; Rubinstein E
J Neurosurg; 1988 Apr; 68(4):648-50. PubMed ID: 3351595
[TBL] [Abstract][Full Text] [Related]
11. [Septicemia by Corynebacterium group JK in a polytraumatized patient (author's transl)].
Wirsing von König CH; Drechsler HJ; Wichmann S; Finger H
Klin Wochenschr; 1982 Mar; 60(5):263-4. PubMed ID: 7078024
[TBL] [Abstract][Full Text] [Related]
12. [Clinical evaluation of sulbactam/cefoperazone for severe infections associated with hematological disorders].
Toyama K; Torii Y; Aoki I; Kikuchi M; Wakasugi K
Jpn J Antibiot; 1992 Aug; 45(8):1003-8. PubMed ID: 1433888
[TBL] [Abstract][Full Text] [Related]
13. Isolation of Corynebacterium group D2 from clinical specimens.
Van Bosterhaut B; Claeys G; Gigi J; Wauters G
Eur J Clin Microbiol; 1987 Aug; 6(4):418-9. PubMed ID: 3665897
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of the pathogenic characteristics of 162 severely burned patients with bloodstream infection].
Gong YL; Yang ZC; Yin SP; Liu MX; Zhang C; Luo XQ; Peng YZ
Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):529-35. PubMed ID: 27647068
[TBL] [Abstract][Full Text] [Related]
15. "Diphtheroid" pneumonia.
Jacobs NF; Perlino CA
South Med J; 1979 Apr; 72(4):475-6. PubMed ID: 432687
[TBL] [Abstract][Full Text] [Related]
16. [Clinical evaluation of sulbactam/cefoperazone for infections during the chemotherapy of hematologic malignancy].
Kawai Y; Ueda T; Iwasaki H; Nakamura T
Jpn J Antibiot; 1994 Sep; 47(9):1196-201. PubMed ID: 7990260
[TBL] [Abstract][Full Text] [Related]
17. [A case of ventilator-associated pneumonia due to Pantoea agglomerans].
Kurşun O; Unal N; Cesur S; Altın N; Canbakan B; Argun C; Koldaş K; Sencan I
Mikrobiyol Bul; 2012 Apr; 46(2):295-8. PubMed ID: 22639319
[TBL] [Abstract][Full Text] [Related]
18. Corynebacterium pseudodiphtheriticum: Putative probiotic, opportunistic infector, emerging pathogen.
Burkovski A
Virulence; 2015; 6(7):673-4. PubMed ID: 26252066
[No Abstract] [Full Text] [Related]
19. [Three-year experience with the use of cefoperazone/sulbactam (sulperazone) in the treatment of hospital-acquired infections in an oncologic hospital].
Antibiot Khimioter; 2006; 51(1):14-7. PubMed ID: 16734360
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of resistant corynebacteria group JK.
Finger H; Wirsing von Koenig CH; Wichmann S; Becker-Boost E; Drechsler HJ
Lancet; 1983 Mar; 1(8323):538. PubMed ID: 6131247
[No Abstract] [Full Text] [Related]
[Next] [New Search]
